Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

25 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    The Patentability of Medicinal Inventions Related to Personalised Medicine in Japan

    As the difficulties in producing new chemical entities continue for pharmaceutical companies, their research strategies have recently emphasised not only the development of new medicines, but also life cycle management. This
    JapanFood, Drugs, Healthcare, Life Sciences
    Lovells
    Lovells
  • Article

    「後発医薬品の安定供給等の実現に向けた産業構造改革のための独占禁 止法関係事例集」の公表

    厚生労働省及び公正取引委員会(以下「公取委」という。)は、2025 年 2 月 17 日、「後発医薬品の安定供給等の実現に 向けた産業構造改革のため
    JapanFood, Drugs, Healthcare, Life Sciences
    Anderson Mori & Tomotsune
    Anderson Mori & Tomotsune
Article

Life Science Newsletter April 2025 (Japanese)

厚生労働省及び経済産業省は、2025 年 3 月 28...
JapanFood, Drugs, Healthcare, Life Sciences
Anderson Mori & Tomotsune
Anderson Mori & Tomotsune
  • Article

    No Drug? No Dice! Clarifying Orange Book Eligibility For Drug-Device Patents

    . . . Viewed in this light, the court's extended analysis of "drug" versus "device" components of an approved drug product may thus introduce unnecessary inconsistencies and complications in future evaluations...
    JapanFood, Drugs, Healthcare, Life Sciences
    YMF Law
    YMF Law
  • Article

    Digital Healthcare 2023

    While Japanese law does not provide formal definitions of digital healthcare and digital medicine, there is a difference in those terms based on whether a product constitutes a "pharmaceutical" or a "medical device" ...
    JapanFood, Drugs, Healthcare, Life Sciences
    Anderson Mori & Tomotsune
    Anderson Mori & Tomotsune
  • Showing 21–25 of 25 results

    Previous
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics